Impaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations

scientific article

Impaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.BBRC.2005.05.032
P698PubMed publication ID15913553
P5875ResearchGate publication ID7827319

P2093author name stringBecker TM
Kefford RF
de la Pena A
Leclercq IA
Mann GJ
Rizos H
Woodruff S
P433issue3
P921main subjectNF-κBQ411114
P304page(s)873-879
P577publication date2005-07-01
P1433published inBiochemical and Biophysical Research CommunicationsQ864228
P1476titleImpaired inhibition of NF-kappaB activity by melanoma-associated p16INK4a mutations
P478volume332

Reverse relations

cites work (P2860)
Q37308298Assessment of functional effects of unclassified genetic variants
Q39564985Classifying variants of CDKN2A using computational and laboratory studies
Q38985389Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151.
Q30375327Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.
Q28291669Good cop, bad cop: the different faces of NF-kappaB
Q33776852IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity
Q42584249INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma
Q80305797Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients
Q36416479NF-kappaB activation in melanoma
Q37149856Systemic targeting inhibitor of kappaB kinase inhibits melanoma tumor growth
Q34683406p16 Protein and gigaxonin are associated with the ubiquitination of NFκB in cisplatin-induced senescence of cancer cells

Search more.